A systematic search was conducted across multiple electronic databases, including MEDLINE, the Cochrane Library, PubMed, Embase, ClinicalTrials.gov, and CINAHL, to identify high-quality, relevant peer-reviewed studies on SGLT2 inhibitors in heart failure patients. Here, SLC5A2 is linked to heart failure.